{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:50:49Z","timestamp":1791388249510,"version":"4.3.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009227","name":"Department of Medicine, University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jbspin.2026.106081","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:42:40Z","timestamp":1779838960000},"page":"106081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Type I Interferon status and clinical manifestations in a large cohort of patients with systemic lupus erythematosus"],"prefix":"10.1016","volume":"93","author":[{"given":"Justin D.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Whittall","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennisse","family":"Bonilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Antonio","family":"Avina-Zubieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemani","family":"Wijesuriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviva","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Reidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Terbrueggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Wither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna D.","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5177-2076","authenticated-orcid":false,"given":"Zahi","family":"Touma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2026.106081_bib0155","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.jbspin.2026.106081_bib0160","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1177\/0961203319885447","article-title":"Type I interferon gene signature test-low and -high patients with systemic lupus erythematosus have distinct gene expression signatures","volume":"28","author":"Brohawn","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.jbspin.2026.106081_bib0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13075-021-02414-0","article-title":"The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus","volume":"23","author":"Mai","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2026.106081_bib0170","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2133.2012.10825.x","article-title":"The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score","volume":"166","author":"Braunstein","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jbspin.2026.106081_bib0175","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1002\/art.22578","article-title":"Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus","volume":"56","author":"Nzeusseu Toukap","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106081_bib0180","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/art.22044","article-title":"Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus","volume":"54","author":"Feng","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106081_bib0185","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106081_bib0190","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/ard.2008.093146","article-title":"Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus","volume":"68","author":"Landolt-Marticorena","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106081_bib0195","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106081_bib0200","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2026.106081_bib0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0961203310385163","article-title":"SLEDAI-2K 10 days versus SLEDAI-2K 30 days in a longitudinal evaluation","volume":"20","author":"Touma","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jbspin.2026.106081_bib0210","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/rheumatology\/key103","article-title":"A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index","volume":"57","author":"Touma","year":"2018","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.jbspin.2026.106081_bib0215","first-page":"824","article-title":"Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE","volume":"32","author":"Iba\u00f1ez","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2026.106081_bib0220","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106081_bib0225","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jmoldx.2014.11.002","article-title":"A novel technology for multiplex gene expression analysis directly from whole blood samples stabilized at ambient temperature using an RNA-stabilizing buffer","volume":"17","author":"Kim","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jbspin.2026.106081_bib0230","doi-asserted-by":"crossref","first-page":"e000625","DOI":"10.1136\/lupus-2021-000625","article-title":"Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis","volume":"9","author":"Northcott","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.jbspin.2026.106081_bib0235","doi-asserted-by":"crossref","first-page":"e000625","DOI":"10.1136\/lupus-2021-000625","article-title":"Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis","volume":"9","author":"Northcott","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.jbspin.2026.106081_bib0240","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adt5550","article-title":"Epigenetic attenuation of interferon signaling is associated with aging-related improvements in systemic lupus erythematosus","volume":"17","author":"Narendra","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jbspin.2026.106081_bib0245","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jbspin.2026.106081_bib0250","doi-asserted-by":"crossref","first-page":"101569","DOI":"10.1016\/j.xcrm.2024.101569","article-title":"Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE","volume":"5","author":"G\u00f3mez-Ba\u00f1uelos","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jbspin.2026.106081_bib0255","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.0022-202X.2005.23889.x","article-title":"The CLASI (Cutaneous LE Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus","volume":"125","author":"Albrecht","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jbspin.2026.106081_bib0260","article-title":"Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE","volume":"5","author":"G\u00f3mez-Ba\u00f1uelos","year":"2024","journal-title":"Cell Rep Med [Internet]"},{"key":"10.1016\/j.jbspin.2026.106081_bib0265","doi-asserted-by":"crossref","first-page":"100246","DOI":"10.1016\/j.jtauto.2024.100246","article-title":"Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus","volume":"9","author":"Kaan","year":"2024","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.jbspin.2026.106081_bib0270","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/art.21890","article-title":"Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies","volume":"54","author":"Hua","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106081_bib0275","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.4049\/jimmunol.1601142","article-title":"Blood-Borne RNA correlates with disease activity and IFN-stimulated gene expression in systemic lupus erythematosus","volume":"197","author":"Doedens","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2026.106081_bib0280","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-immunol-101921-042422","article-title":"Systemic lupus erythematosus pathogenesis: interferon and beyond","volume":"41","author":"Caielli","year":"2023","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jbspin.2026.106081_bib0285","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1038\/s41598-023-29772-w","article-title":"Risk of systemic lupus erythematosus flares according to autoantibody positivity at the time of diagnosis","volume":"13","author":"Kwon","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jbspin.2026.106081_bib0290","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/art.20254","article-title":"Induction of interferon-\u03b1 production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG","volume":"50","author":"L\u00f6vgren","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106081_bib0295","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/14397595.2019.1583833","article-title":"Safety and tolerability of anifrolumab, a monoclonal antibody targeting type I interferon receptor, in Japanese patients with systemic lupus erythematosus: a multicenter, phase 2, open-label study","volume":"30","author":"Tanaka","year":"2020","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jbspin.2026.106081_bib0300","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X26000503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X26000503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:55:34Z","timestamp":1791384934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X26000503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1297319X26000503"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2026.106081","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type I Interferon status and clinical manifestations in a large cohort of patients with systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2026.106081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie.","name":"copyright","label":"Copyright"}],"article-number":"106081"}}